Implications of the EU HTA Process for Manufacturers


On Wednesday 26th April, our Managing Directors and Market Access Experts Dr Paul Craddy and Dr Graham Foxon hosted a live webinar, to discuss the latest news and updates on the upcoming EU HTA , including implications of the process for manufacturers.

To view the webinar on demand, please click the PLAY button below.

If you have any questions or would like to discuss the topic in more detail, please reach out.

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.